Viking Therapeutics (VKTX) CEO Brian Lian on Q2 2018 Results - Earnings Call Transcript [Seeking Alpha]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Seeking Alpha
Viking Therapeutics (NASDAQ: VKTX ) Q2 2018 Results Earnings Conference Call August 9, 2018 4:30 PM ET Executives Stephanie Diaz - Manager of IR Brian Lian - President and CEO Michael Morneau - VP of Finance and Administration Analysts Steven Seedhouse - Raymond James. Joe Pantginis - H.C. Wainwright Andy Hsieh - William Blair Scott Henry - ROTH Capital Yale Jen - Laidlaw and Company Caroline Palomeque - Maxim Group Operator Good day and welcome to the Viking Therapeutics Second Quarter 2018 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Stephanie Diaz, Manager of Investor Relations. Please go ahead. Stephanie Diaz Hello, and thank you all for participating in today's call. Joining me today is Brian Lian, Viking's President and CEO, and Michael Morneau, Vice President of Finance and Administration. Before we begin, I'd like to caution that comments
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- 11 Oversold MidCap Stocks To Buy Now [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.MarketBeat
- Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at StockNews.com to a "sell" rating.MarketBeat
- Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdatePR Newswire
VKTX
Earnings
- 4/24/24 - Beat
VKTX
Sec Filings
- 4/25/24 - Form 10-Q
- 4/24/24 - Form 8-K
- 4/5/24 - Form ARS
- VKTX's page on the SEC website